Custom financial tombstone commemorating an offering by Artelo Biosciences, a San Diego-based biopharmaceutical firm.
(20AJH203)Custom financial tombstone commemorating an offering by Artelo Biosciences, a San Diego-based biopharmaceutical firm.
(20AJH203)Custom deal toy celebrating a follow-on public offering by Applied UV, a technology company employing narrow-range ultra violet light (UVC) to combat pathogens.
(20AJH232)Lucite tombstone celebrating Series A funding for Trailhead Biosystems. The Cleveland-based biotechnology company is focused on the application of machine-enabled technology.
(21ADH001)Lucite tombstone celebrating a private placement and concurrent global offering of shares by Calliditas Therapeutics. Joint bookrunners in the offering by the Swedish biotech firm were Citi, Jefferies, and Stifel.
(20ALJ348)Crystal deal toy commemorating the acquisition of Philadelphia-based Spark Therapeutics. The acquiring firm, Swiss pharmaceutical firm Roche, is headquartered in Basel.
(9ALJ621)Crystal deal toy, incorporating an interior, 3-D etching of Thor’s hammer, commemorating a private placement by pharmaceutical company Photocure ASA. Based in Oslo, Norway, Photocure specializes in photodynamic therapies that make use of light-activated drugs.
(20LJW163)Crystal deal toy celebrating the initial public offering by pharmaceutical firm Rua Bioscience. The New Zealand-based company is licensed to produce cannabis-derived medicines.
(20ALJ334)Custom crystal celebrating the submission of a New Drug Application (NDA) to the Food and Drug Administration (FDA). The application, related to Impel NeuroPharma’s migraine treatment INP104, was supported by a Phase 3, open-label STOP-301 Trial.
(20ALJ356)